Engineered viruses that don’t replicate provide a tractable model for scientists to safely study SARS-CoV-2, including research into vaccine efficacy and emerging variants.

An inflatable biosafety laboratory may help meet the global need for testing infrastructure during the COVID-19 pandemic.

Researchers have rapidly identified ways to apply their expertise to help end the pandemic.

A large-scale shortage of respirators and face shields threatens progress in some labs that are currently trying to ramp up their studies of SARS-CoV-2.

The agency cites lapses in biosafety procedures at the US Army Medical Research Institute of Infectious Diseases in Maryland.

Two professors have been arrested for negligence in connection with the blast.

Only a few labs will earn funding for such “gain-of-function” research on SARS, MERS, and other deadly diseases.

Genetically modified bacteria that don’t survive unless given an unnatural amino acid could serve as a new control measure to protect wild organisms and ecosystems against accidental release. 

After a string of breaches involving anthrax, Ebola, and bird flu, the US Centers for Disease Control and Prevention has reportedly replaced the director of its Division of Select Agents and Toxins.

“Kill switches” ensure that genetically engineered bacteria survive only in certain environmental conditions.

Researchers have developed two methods to avoid the unchecked spread of engineered genes through wild populations.

As the world inches closer to polio eradication, laboratories studying the virus will have to bolster biosafety standards. Eventually, most will need to stop working with the pathogen entirely.

A US Army lab shipped live spores of the deadly bacterium because of improper irradiation protocols, a Department of Defense review has found.

The Defense Department reports that live samples of the deadly bacterium may have been accidentally shipped to more than 50 labs in the U.S. and abroad.

In the wake of numerous safety breaches at the federal agency, a new report finds US Centers for Disease Control and Prevention oversight “inconsistent and insufficient at multiple levels.”

Scientists design bacteria reliant upon synthetic amino acids to contain genetically modified organisms.

In the wake of numerous biosafety breaches, the US Centers for Disease Control and Prevention looks to hire a chief of laboratory safety.

A Centers for Disease Control and Prevention lab mistakenly transferred the wrong Ebola samples—ones that may have contained live virus—to another agency lab.